Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.17 USD | -0.35% | -1.54% | -3.76% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.76% | 1.78B | |
+31.66% | 695B | |
+26.51% | 568B | |
-4.73% | 361B | |
+19.50% | 330B | |
+3.50% | 283B | |
+16.81% | 239B | |
+8.75% | 204B | |
-7.85% | 198B | |
+8.78% | 168B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Mizuho Boosts PT on Harmony Biosciences to $42 From $33 Ahead of Q4 2023 Earnings Announcement, Maintains Buy Rating